Merck to donate Ebola vaccine candidate for research program in Uganda

Reuters Merck & Co (MRK.N) said on Tuesday it was planning to produce and donate investigational Sudan ebolavirus vaccine to a global non-profit organization’s research program in Uganda, which is facing an outbreak of the disease. The investigational vaccine that will be donated to IAVI is similar to Merck’s Ervebo vaccine, which is approved against the Zaire…

WHO urges switch to one-dose vaccine strategy against cholera due to shortage

By Halligan Agade In response to a shortage of vaccines, the World Health Organisation (WHO) is recommending countries temporarily suspend administering two-dose treatments for cholera and opt for a single-dose shot instead. The recommendation comes as several nations report unprecedented surges in cholera outbreaks. Nearly 29 countries across the world have recorded cholera cases since January…